Viewing Study NCT01693068


Ignite Creation Date: 2025-12-24 @ 6:27 PM
Ignite Modification Date: 2026-01-19 @ 7:09 PM
Study NCT ID: NCT01693068
Status: COMPLETED
Last Update Posted: 2018-01-05
First Post: 2012-09-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma
Sponsor:
Organization: